Response to the commentaries

Journal of Mental Health

Volumn 12, Issue 4, 2003, Pages 363-367

  Morrison, Anthony P ^a   Bentall, Richard P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; TAMOXIFEN;

BREAST CANCER; CLINICAL TRIAL; COGNITIVE THERAPY; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG SAFETY; HIGH RISK PATIENT; HUMAN; NOTE; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0042324400     PISSN: 09638237     EISSN: None     Source Type: Journal    
DOI: 10.1080/0963823031000153501     Document Type: Note

References (11)

1. Bentall, R.P. (2003). Madness Explained: Psychosis and Human Nature. London: Penguin.
2. Cornblatt, B.A., Lencz, T. & Kane, J.M. (2001). Treatment of the schizophrenia prodrome: Is is presently ethical? Schizophrenia Research, 51, 31-38.
3. Cornwell, J. (1996). The Power to Harm: Mind, Murder and Drugs on Trial. London: Penguin Books.
4. French, P., Morrison, A.P., Walford, L., Knight, A. & Bentall, R.P. (2003). Cognitive therapy for preventing transition to psychosis in high risk individuals: A case series. Behavioural and Cognitive Psychotherapy, 31, 53-68.
5. Geddes, J., Freemantle, N., Harrison, P. & Bebbington, P. (2000). Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis. British Medical Journal, 321, 1371-1376.
6. Healy, D. (2002). Conflicting interests in Toronto: Anatomy of a controversy at the interface of academia and industry. Perspectives in Biology and Medicine, 45, 250-263.
7. Le Fanu, J. (1999). The Rise and Fall of Modern Medicine. London: Little, Brown and Co.
8. Lexchin, J., Bero, L.A., Djulbegovic, B. & Clark, O. (2003). Pharmaceutical industry sponsorship and research outcome and quality: systematic review. British Medical Journal, 326(7400), 1167-1170.
9. McGorry, P.D., Yung, A.R., Phillips, L.J., Yuen, H.P., Francey, S., Cosgrave, E.M., Germano, D., Bravin, J., McDonald, T., Blair, A., Adlard, S. & Jackson, H. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59(10), 921-928.
10. Melander, H., Ahlqvist-Rastad, J., Meijer, G., & Beermann, B. (2003). Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. British Medical Journal, 326(7400), 1171-1173.
11. Whitaker, R. (2002). Mad in America: Bad science, bad medicine and the enduring mistreatment of the mentally ill. New York: Perseus Books.